Clinical Trial Update: The Effect of Pirfenidone on Cough in Patients With Idiopathic Pulmonary Fibrosis

View source ↗

Summary

This clinical trial update reports that a study evaluating the effect of pirfenidone on cough in idiopathic pulmonary fibrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• Pirfenidone (Esbriet) (pirfenidone)

Snippet

Sponsor: Erasmus Medical Center | Conditions: Idiopathic Pulmonary Fibrosis | Status: COMPLETED